ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients

This study has been completed.
Information provided by University of Pittsburgh

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients
Official Title  Acupuncture for Cancer-Related Fatigue in Breast Cancer Patients
Brief Summary

This study will evaluate if acupuncture is helpful in treating cancer-related fatigue in breast cancer patients undergoing radiation therapy.

Detailed Description

Each participant will have a baseline visit before her radiation therapy begins to complete questionnaires. Participants will receive either true acupuncture or sham acupuncture twice per week for the six weeks of radiation therapy. She will have a short questionnaire at three weeks into her radiation, and she will complete questionnaires again at the end of her radiation and four weeks later.

Study Phase Phase I
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Primary Outcome Measure  Cancer-related fatigue [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Cancer-related fatigue distress [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
Quality of life [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
Condition  Fatigue
Intervention  Procedure: acupuncture
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Completed
Enrollment  54
Start Date  September 2005
Completion Date September 2007
Eligibility Criteria 

Inclusion Criteria:

  • Localized breast cancer
  • Average to above average fatigue
  • Planning radiation therapy

Exclusion Criteria:

  • History of acupuncture treatment
  • Allergy to stainless steel
  • Pacemaker
  • Anticoagulant therapy
  • Known bleeding disorder
  • Metastatic breast cancer
  • Seizure disorder
Gender Female
Ages 21 Years and older
Accepts Healthy Volunteers No
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00177840
Organization ID 0506139
Secondary IDs †† R21 CA098659-01A2
Study Sponsor  University of Pittsburgh
Collaborators †† National Institutes of Health (NIH)
National Cancer Institute (NCI)
Investigators 
Principal Investigator:     Judith Balk, MD MPH     University of Pittsburgh    
Information Provided By University of Pittsburgh
Verification Date March 2008
First Received Date  September 13, 2005
Last Updated Date March 27, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers